Bml Capital Management, LLC Avrobio, Inc. Transaction History
Bml Capital Management, LLC
- $149 Billion
- Q1 2024
A detailed history of Bml Capital Management, LLC transactions in Avrobio, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 4,001,627 shares of AVRO stock, worth $5.56 Million. This represents 3.43% of its overall portfolio holdings.
Number of Shares
4,001,627
Previous 4,001,627
-0.0%
Holding current value
$5.56 Million
Previous $5.44 Billion
5.88%
% of portfolio
3.43%
Previous 4.12%
Shares
2 transactions
Others Institutions Holding AVRO
# of Institutions
50Shares Held
28.1MCall Options Held
9KPut Options Held
100-
Atlas Venture Life Science Advisors, LLC4.54MShares$6.31 Million0.73% of portfolio
-
Adar1 Capital Management, LLC Austin, TX3.95MShares$5.5 Million1.15% of portfolio
-
Verition Fund Management LLC Greenwich, CT1.93MShares$2.68 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$2.61 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.24MShares$1.72 Million0.01% of portfolio
About AVROBIO, Inc.
- Ticker AVRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,773,900
- Market Cap $60.8M
- Description
- AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...